Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vanda Pharmaceuticals Inc. - Common Stock
(NQ:
VNDA
)
5.100
-0.080 (-1.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
540,612
Open
5.160
Bid (Size)
5.000 (700)
Ask (Size)
5.300 (100)
Prev. Close
5.180
Today's Range
4.950 - 5.160
52wk Range
4.140 - 9.940
Shares Outstanding
55,638,166
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vanda (VNDA) Q1 2026 Earnings Call Transcript
↗
May 06, 2026
Vanda (VNDA) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Intellectual Property
VANDA PHARMACEUTICALS INC (NASDAQ:VNDA) Misses Q1 2026 Estimates as Top-Line Growth Slows
↗
May 06, 2026
Via
Chartmill
Performance
YTD
-38.2%
-38.2%
1 Month
-15.7%
-15.7%
3 Month
-27.1%
-27.1%
6 Month
-32.4%
-32.4%
1 Year
+19.7%
+19.7%
More News
Read More
Curious about the stocks that are showing activity after the closing bell on Friday?
↗
May 01, 2026
Via
Chartmill
Vanda Now Looks To Public Hearing For Hetlioz In Jet Lag Disorder After Multiple FDA Rejections
↗
March 03, 2026
Via
Stocktwits
Why Did Vanda Pharmaceuticals Stock Slide 7% Pre-Market Today?
↗
February 12, 2026
Via
Stocktwits
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Stock Plummets 9.8% After Mixed Q4 2025 Earnings Report
↗
February 11, 2026
Via
Chartmill
Vanda Stock Drop 10% Premarket After FDA Rejects Jet Lag Drug Application
↗
January 08, 2026
Via
Stocktwits
Vanda Pharma Stock Rises Pre-Market After FDA Accepts Imsidolimab Filing For Rare Skin Disorder
↗
February 25, 2026
Via
Stocktwits
In today's session, these stocks are experiencing unusual volume.
↗
February 24, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
February 23, 2026
Via
Chartmill
Here are the top movers in Monday's session.
↗
February 23, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
February 23, 2026
Via
Chartmill
These stocks are moving in today's pre-market session
↗
February 23, 2026
Via
Chartmill
Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today
↗
February 23, 2026
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
Government
VNDA Stock Soars 40% Overnight After Bysanti Approval: What’s The Next Catalyst And How Much Upside Remains?
↗
February 22, 2026
Via
Stocktwits
VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug
↗
February 20, 2026
Via
Stocktwits
Vanda Stock Draws Heavy Buzz Ahead Of FDA Verdict On Bysanti For Bipolar, Schizophrenia
↗
February 19, 2026
Via
Stocktwits
Vanda (VNDA) Q4 2025 Earnings Call Transcript
↗
February 11, 2026
Via
The Motley Fool
Topics
Earnings
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
February 03, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 27, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 20, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 13, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
January 08, 2026
Via
Chartmill
In today's session, these stocks are experiencing unusual volume.
↗
January 02, 2026
Via
Chartmill
What's Going On With Vanda Pharmaceuticals Stock Wednesday?
↗
December 31, 2025
Via
Benzinga
Frequently Asked Questions
Is Vanda Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Vanda Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Vanda Pharmaceuticals Inc. - Common Stock trade on?
Vanda Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock is VNDA on the Nasdaq Stock Market
What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?
The current price of Vanda Pharmaceuticals Inc. - Common Stock is 5.100
When was Vanda Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 07/31/26 04:00 PM ET
What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?
The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 283.75M
How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?
Vanda Pharmaceuticals Inc. - Common Stock has 284M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
